Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients

Cancer

Volumn 117, Issue 2, 2011, Pages 250-258

  Liu, Liang Chih ^a,b   Lang, Julie E ^a,c   Lu, Ying ^a,d   Roe, Denise ^e,f   Hwang, Shelley E ^a   Ewing, Cheryl A ^a   Esserman, Laura J ^a   Morita, Eugene ^g   Treseler, Patrick ^g   Leong, Stanley P ^a,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

breast cancer; frozen section; intraoperative evaluation; meta analysis; sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CELL; CANCER PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; MICROMETASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FROZEN SECTIONS; HUMANS; INTRAOPERATIVE PERIOD; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 78650993713     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25606     Document Type: Article

References (86)

1. Schwartz GF, Giuliano AE, Veronesi U, et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 2002; 94: 2542-2551. (Pubitemid 34478066)
2. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003; 95: 1514-1521.
3. Giuliano AE,. Sentinel node biopsy: standard of care. Breast J. 2003; 9: S3-S6.
4. Singh-Ranger G, Mokbel K,. The sentinel node biopsy is a new standard of care for patients with early breast cancer. Int J Fertil Womens Med. 2004; 49: 225-227.
5. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003; 349: 546-553.
6. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancera a multicenter validation study. N Engl J Med. 1998; 339: 941-946.
7. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter triala Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999; 230: 453-465.
8. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127: 392-399.
9. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995; 5: 255-260.
10. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994; 220: 759-767.
11. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000; 18: 2553-2559.
12. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000; 88: 608-614.
13. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC,. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002; 183: 23-27.
14. Temple LK, Baron R, Cody HS 3rd, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002; 9: 654-662.
15. Haid A, Kuehn T, Konstantiniuk P, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol. 2002; 28: 705-710.
16. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM,. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002; 9: 745-753.
17. Golshan M, Martin WJ, Dowlatshahi K,. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003; 69: 209-212.
18. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003; 29: 341-350.
19. Peintinger F, Reitsamer R, Stranzl H, Ralph G,. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer. 2003; 89: 648-652. (Pubitemid 37076167)
20. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007; 25: 3657-3663.
21. Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ,. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol. 2007; 14: 1653-1661.
22. Treseler PA, Tauchi PS,. Pathologic analysis of the sentinel lymph node. Surg Clin North Am. 2000; 80: 1695-1719.
23. Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr,. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med. 2003; 127: 701-705.
24. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23: 7703-7720.
25. Leong SP, Morita ET, Treseler PA, Wong JH,. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Cancer. 2000; 7: 105-113.
26. Leong SP, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg. 1997; 132: 666-672; discussion 673.
27. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
28. Singletary SE, Connolly JL,. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006; 56: 37-47.
29. McClish DK,. Combining and comparing area estimates across studies or strata. Med Decis Making. 1992; 12: 274-279.
30. R Foundation for Statistical Computing. The R Project for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Accessed December 6, 2008.
31. Langer I, Guller U, Berclaz G, et al. for the Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat. 2009; 113: 129-136.
32. Arora N, Martins D, Huston TL, et al. Sentinel node positivity rates with and without frozen section for breast cancer. Ann Surg Oncol. 2008; 15: 256-261.
33. McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS 3rd, Sclafani LM,. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. J Am Coll Surg. 2008; 206: 76-82.
34. Shimazu K, Tamaki Y, Taguchi T, Tsukamoto F, Kasugai T, Noguchi S,. Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2008; 15: 1717-1722.
35. Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg. 2000; 87: 597-601.
36. Nahrig JM, Richter T, Kuhn W, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J. 2003; 9: 277-281.
37. Choi YJ, Yun HR, Yoo KE, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer. Jpn J Clin Oncol. 2006; 36: 489-493.
38. Van Diest PJ, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. 1999; 35: 14-18.
39. Flett MM, Going JJ, Stanton PD, Cooke TG,. Sentinel node localization in patients with breast cancer. Br J Surg. 1998; 85: 991-993.
40. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997; 349: 1864-1867.
41. Krogerus LA, Leidenius MH, Toivonen TS, von Smitten KJ,. Towards reasonable workload in diagnosis of sentinel lymph nodes: comparison of 2 frozen section methods. Histopathology. 2004; 44: 29-34.
42. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg. 1999; 229: 528-535.
43. Noguchi M, Bando E, Tsugawa K, et al. Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat. 1999; 57: 221-229.
44. Turner RR, Hansen NM, Stern SL, Giuliano AE,. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol. 1999; 112: 627-634.
45. Morgan A, Howisey RL, Aldape HC, et al. Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. J Surg Oncol. 1999; 72: 24-30; discussion 30-31.
46. Rahusen FD, Pijpers R, Van Diest PJ, Bleichrodt RP, Torrenga H, Meijer S,. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery. 2000; 128: 6-12.
47. Weiser MR, Montgomery LL, Susnik B, Tan LK, Borgen PI, Cody HS,. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol. 2000; 7: 651-655.
48. Imoto S, Fukukita H, Murakami K, Ikeda H, Moriyama N,. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol. 2000; 73: 130-133.
49. Gemignani ML, Cody HS 3rd, Fey JV, Tran KN, Venkatraman E, Borgen PI,. Impact of sentinel lymph node mapping on relative charges in patients with early-stage breast cancer. Ann Surg Oncol. 2000; 7: 575-580.
50. Liu LH, Siziopikou KP, Gabram S, McClatchey KD,. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma. Arch Pathol Lab Med. 2000; 124: 1670-1673.
51. Gulec SA, Su J, O'Leary JP, Stolier A,. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg. 2001; 67: 529-532.
52. van der Loo EM, Sastrowijoto SH, Bril H, van Krimpen C, de Graaf PW, Eulderink F,. Less operations required due to perioperative frozen section examination of sentinel nodes in 275 breast cancer patients. Ned Tijdschr Geneeskd. 2001; 145: 1986-1991.
53. Tanis PJ, Boom RP, Koops HS, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol. 2001; 8: 222-226.
54. Zurrida S, Mazzarol G, Galimberti V, et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol. 2001; 8: 817-820.
55. Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg. 2001; 182: 609-615.
56. Nagashima T, Suzuki M, Yagata H, et al. Intraoperative cytologic diagnosis of sentinel node metastases in breast cancer. Acta Cytol. 2003; 47: 1028-1032.
57. Leidenius MH, Krogerus LA, Toivonen TS, Von Smitten KJ,. The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer. J Surg Oncol. 2003; 84: 68-73.
58. Liang R, Craik J, Juhasz ES, Harman CR,. Imprint cytology versus frozen section: intraoperative analysis of sentinel lymph nodes in breast cancer. ANZ J Surg. 2003; 73: 597-599.
59. Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A., Estabrook A,. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol. 2003; 10: 1166-1170.
60. D'Errico A, Grassigli A, Gruppioni E, et al. Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. Surgery. 2004; 135: 248-254; discussion 255-257, 357. (Pubitemid 38297373)
61. Lauridsen MC, Garne JP, Sorensen FB, Melsen F, Lernevall A, Christiansen P,. Sentinel lymph node biopsy in breast cancera experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. Acta Oncol. 2004; 43: 20-26.
62. Holck S, Galatius H, Engel U, Wagner F, Hoffmann J,. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast. 2004; 13: 42-48.
63. Wada N, Imoto S, Hasebe T, Ochiai A, Ebihara S, Moriyama N,. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol. 2004; 34: 113-117.
64. Aihara T, Munakata S, Morino H, Takatsuka Y,. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol. 2004; 11: 747-750.
65. Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C,. 200 Sentinel lymph node biopsies without axillary lymph node dissectiona no axillary recurrences after a 3-year follow-up. Br J Cancer. 2004; 90: 1551-1554.
66. Khalifa K, Pereira B, Thomas VA, Mokbel K,. The accuracy of intraoperative frozen section analysis of the sentinel lymph nodes during breast cancer surgery. Int J Fertil Womens Med. 2004; 49: 208-211.
67. Mitchell ML,. Frozen section diagnosis for axillary sentinel lymph nodes: the first 6 years. Mod Pathol. 2005; 18: 58-61.
68. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW,. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg. 2005; 92: 1494-1497.
69. Cao Y, Paner GP, Rajan PB,. Sentinel node status and tumor characteristics: a study of 234 invasive breast carcinomas. Arch Pathol Lab Med. 2005; 129: 82-84.
70. Perez N, Vidal-Sicart S, Zanon G, et al. A practical approach to intraoperative evaluation of sentinel lymph node biopsy in breast carcinoma and review of the current methods. Ann Surg Oncol. 2005; 12: 313-321.
71. Al-Shibli KI, Mohammed HA, Mikalsen KS,. Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section. Ann Saudi Med. 2005; 25: 111-114.
72. Grabau DA, Rank F, Friis E,. Intraoperative frozen section examination of axillary sentinel lymph nodes in breast cancer. APMIS. 2005; 113: 7-12.
73. Brogi E, Torres-Matundan E, Tan LK, et al. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol. 2005; 12: 173-180.
74. Schrenk P, Konstantiniuk P, Wolfl S, et al. Intraoperative frozen section examination of the sentinel lymph node in breast cancer. Rozhl Chir. 2005; 84: 217-222.
75. Celebioglu F, Sylvan M, Perbeck L, Bergkvist L, Frisell J,. Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgerya a prospective study. Eur J Cancer. 2006; 42: 617-620.
76. Leung KM, Chan KW, Yeoh GP, Chan JK, Cheung PS,. Clinical relevance of intraoperative sentinel lymph node examination in breast cancer management. Hong Kong Med J. 2007; 13: 8-11.
77. Anderson TJ,. The challenge of sentinel lymph node biopsy. Histopathology. 1999; 35: 82-84.
78. Pfeifer JD,. Sentinel lymph node biopsy. Am J Clin Pathol. 1999; 112: 599-602.
79. Patrick T,. Pathologic examination of the sentinel lymph node: what is the best method? Breast J. 2006; 12: S143-S151.
80. Giuliano AE, McCall LM, Beitsch PD, et al. ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node [abstract]. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 4-8, 2010; Chicago, Ill. Abstract CRA506.
81. Viale G, Dell'orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008; 247: 136-142.
82. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P,. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005; 92: 1068-1080.
83. Llatjos M, Castella E, Fraile M, et al. Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma: accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer. 2002; 96: 150-156.
84. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999; 85: 2433-2438.
85. Cserni G,. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol. 1999; 52: 922-924. (Pubitemid 30005368)
86. Specht MC, Fey JV, Borgen PI, Cody HS 3rd,. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg. 2005; 200: 10-14.